Lymphatics in the central nervous system are attracting both controversy and drug hunters in search of therapeutic targets for a host of diseases.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Translational Neurodegeneration Open Access 21 March 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. Brain’s drain. Nat Biotechnol 38, 258–262 (2020). https://doi.org/10.1038/s41587-020-0443-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0443-1
This article is cited by
-
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Translational Neurodegeneration (2022)
-
The glymphatic system: implications for drugs for central nervous system diseases
Nature Reviews Drug Discovery (2022)